Skip to Content
Resources

AHIP Comments on Medicare and Medicaid Programs: Regulation to Require Drug Pricing Transparency

Comment Letter

Document Info

Published on Dec 17, 2018

Download and read the full Resource.

Related Issues
High-Price Drugs

Resource Details

AHIP Comment letter to Seema Verma, the Administrator of the Center for Medicare and Medicaid Services, on the proposed rule that would require direct-to-consumer (DTC) prescription drug television ads to include information about the list price of the drug or biological product.

Download the full comment letter below